Provided by Tiger Trade Technology Pte. Ltd.

Myers

20.67
-0.0400-0.19%
Post-market: 20.670.00000.00%16:10 EDT
Volume:218.16K
Turnover:4.51M
Market Cap:773.22M
PE:22.23
High:20.91
Open:20.84
Low:20.43
Close:20.71
52wk High:24.03
52wk Low:9.06
Shares:37.41M
Float Shares:36.71M
Volume Ratio:1.04
T/O Rate:0.59%
Dividend:0.54
Dividend Rate:2.61%
EPS(TTM):0.9300
EPS(LYR):0.9300
ROE:12.22%
ROA:6.23%
PB:2.63
PE(LYR):22.23

Loading ...

Trulieve Expands Florida Footprint With New Fort Myers Medical Cannabis Dispensary

TIPRANKS
·
Jan 26

Janux Therapeutics: Bristol Myers Collaboration Validates Tumor-Activated Platform and Enhances Risk–Reward Profile

TIPRANKS
·
Jan 23

Eurowag Strengthens Board with Appointment of Independent Non-Executive Director Linda Myers

TIPRANKS
·
Jan 22

Veradigm Extends Board Observer Agreement with Charles Myers

TIPRANKS
·
Jan 21

Draganfly Drones Integrated with Smith Myers Tech Deployed by Search and Rescue Sweden

TIPRANKS
·
Jan 14

Bristol Myers price target raised to $60 from $54 at Leerink

TIPRANKS
·
Jan 13

Bristol-Myers CEO Sees 'Wave' of Approvals, Launches by 2030 -- Market Talk

Dow Jones
·
Jan 13

Bristol-Myers CEO Says Diversified Product Line Driving Growth -- Market Talk

Dow Jones
·
Jan 13

Bristol Myers price target raised to $60 from $53 at Scotiabank

TIPRANKS
·
Jan 09

Myers Industries Inc. Files Initial Statement of Beneficial Ownership for SVP and CHRO Lorelei Evans

Reuters
·
Jan 08

Myers Industries Facility Achieves ISO 14001:2015 Environmental Certification

Reuters
·
Dec 17, 2025

Bristol Myers Trades At Trough Valuation — Analyst Says Pipeline Upside Is Being Ignored

Benzinga
·
Dec 16, 2025

Myers Industries' (NYSE:MYE) 79% YoY earnings expansion surpassed the shareholder returns over the past year

Simply Wall St.
·
Dec 12, 2025

Market Chatter: Bristol-Myers' Bid to Dismiss Lawsuit Related to Celgene Acquisition Rejected by US Judge

MT Newswires Live
·
Dec 02, 2025

Bristol Myers says EC grants approval to Breyanzi for treatment of MCL

TIPRANKS
·
Nov 25, 2025

Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study

Benzinga_recent_news
·
Nov 25, 2025

Myers Industries CFO Samantha Rutty Acquires Common Shares

Reuters
·
Nov 19, 2025

Bristol Myers Shares Sink on Yet Another Trial Failure -- Barrons.com

Dow Jones
·
Nov 15, 2025

Bristol Myers Shares Sink on Yet Another Trial Failure -- Barrons.com

Dow Jones
·
Nov 15, 2025

Myers Industries Names Kari Brashear Chief Legal Officer and Senior VP

Reuters
·
Nov 14, 2025